Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
- 15 May 2009
- journal article
- Published by Taylor & Francis Ltd in Cancer Biology & Therapy
- Vol. 8 (10), 939-950
- https://doi.org/10.4161/cbt.8.10.8213
Abstract
The PRC2 complex protein EZH2 is a histone methyltransferase that is known to bind and recruit DNMT1 to the DNA to modulate DNA methylation. Here, we determined that the pan-HDAC inhibitor panobinostat (LBH589) treatment depletes DNMT1 and EZH2 protein levels, disrupts the interaction of DNMT1 with EZH2, as well as de-represses JunB in human acute leukemia cells. Similar to treatment with the hsp90 inhibitor 17-DMAG, treatment with panobinostat also inhibited the chaperone association of heat shock protein 90 with DNMT1 and EZH2, which promoted the proteasomal degradation of DNMT1 and EZH2. Unlike treatment with the DNA methyltransferase inhibitor decitabine, which demethylates JunB promoter DNA, panobinostat treatment mediated chromatin alterations in the JunB promoter. Combined treatment with panobinostat and decitabine caused greater attenuation of DNMT1 and EZH2 levels than either agent alone, which was accompanied by more JunB de-repression and loss of clonogenic survival of K562 cells. Co-treatment with panobinostat and decitabine also caused more loss of viability of primary AML but not normal CD34+ bone marrow progenitor cells. Collectively, these findings indicate that co-treatment with panobinostat and decitabine targets multiple epigenetic mechanisms to de-repress JunB and exerts antileukemia activity against human acute myeloid leukemia cells.Keywords
This publication has 65 references indexed in Scilit:
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylationNature Genetics, 2008
- HSP90: The Rosetta stone for cellular protein dynamics?Cell Cycle, 2008
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- Mammalian Cytosine DNA Methyltransferase Dnmt1: Enzymatic Mechanism, Novel Mechanism-Based Inhibitors, and RNA-directed DNA MethylationCurrent Medicinal Chemistry, 2008
- Histone Deacetylase Inhibitors: Overview and PerspectivesMolecular Cancer Research, 2007
- Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90Clinical Cancer Research, 2007
- Inhibition of Hsp90: A Multitarget Approach to RadiosensitizationClinical Cancer Research, 2007
- Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathminHepatology, 2007
- On the enzymatic properties of Dnmt1: specificity, processivity, mechanism of linear diffusion and allosteric regulation of the enzyme.Epigenetics, 2006
- DNA methyltransferase Dnmt1 associates with histone deacetylase activityNature Genetics, 2000